Followers | 504 |
Posts | 10140 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Thursday, December 04, 2014 2:41:09 PM
bullish
$RDY recent news/filings
## source: finance.yahoo.com
Mon, 24 Nov 2014 07:29:00 GMT ~ Dr. Reddy’s Announces the Launch of Docetaxel Injection USP
[Business Wire] - HYDERABAD, India--(BUSINESSWIRE)-- Dr. Reddy’s Laboratories (NYSE: RDY) announced today that is has launched Docetaxel Injection USP 20 mg/mL and 80 mg/4 mL a therapeutic equivalent generic version of ...
read full: http://au.finance.yahoo.com/news/dr-reddy-announces-launch-docetaxel-072900029.html
*********************************************************
Mon, 24 Nov 2014 07:29:00 GMT ~ Dr. Reddy’s Announces the Launch of Docetaxel Injection USP
[Business Wire] - Dr. Reddy’s Laboratories announced today that is has launched Docetaxel Injection USP 20 mg/mL and 80 mg/4 mL a therapeutic equivalent generic version of TAXOTERE® in the US market on November 21, 2014.
read full: http://finance.yahoo.com/news/dr-reddy-announces-launch-docetaxel-072900058.html
*********************************************************
Thu, 20 Nov 2014 23:03:13 GMT ~ Consumer Retail/Spending top the Lg Cap List...
read full: http://finance.yahoo.com/tumblr/blog-consumer-retail-spending-top-the-lg-cap-list-230315654.html
*********************************************************
Thu, 20 Nov 2014 14:15:00 GMT ~ Dr. Reddy’s Announces the Launch of Over-the-Counter Fexofenadine Hydrochloride 60 mg and Pseudoephedrine Hydrochloride 120 mg Extended-Release Tablets
[Business Wire] - HYDERABAD, India--(BUSINESSWIRE)-- Dr. Reddy’s Laboratories (NYSE: RDY) announced today that it has launched its over-the-counter (OTC) Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride Extended ...
read full: http://au.finance.yahoo.com/news/dr-reddy-announces-launch-over-141500549.html
*********************************************************
Thu, 20 Nov 2014 14:15:00 GMT ~ Dr. Reddy’s Announces the Launch of Over-the-Counter Fexofenadine Hydrochloride 60 mg and Pseudoephedrine Hydrochloride 120 mg Extended-Release Tablets
[Business Wire] - Dr. Reddy’s Laboratories announced today that it has launched its over-the-counter Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride Extended Release Tablets 60 mg / 120 mg, a bioequivalent generic version of Allegra-D® 12 Hour Allergy & Congestion, in the U.S.
read full: http://finance.yahoo.com/news/dr-reddy-announces-launch-over-141500492.html
*********************************************************
$RDY charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$RDY company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/RDY/company-info
Ticker: $RDY
OTC Market Place: Not Available
CIK code: 0001135951
Company name: Dr. Reddy's Laboratories Ltd.
Company website: http://www.drreddys.com
Incorporated In: India
$RDY share structure
## source: otcmarkets.com
Market Value: Not Available
Shares Outstanding: Not Available
Float: Not Available
Authorized Shares: Not Available
Par Value: No Par Value
$RDY extra dd links
Company name: Dr. Reddy's Laboratories Ltd.
Company website: http://www.drreddys.com
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/RDY/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/RDY/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=RDY+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=RDY+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=RDY+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/RDY/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/RDY/news - http://finance.yahoo.com/q/h?s=RDY+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/RDY/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/RDY/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/RDY/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/RDY/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/RDY/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/RDY/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/RDY/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/RDY/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=RDY+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/RDY
DTCC (dtcc.com): http://search2.dtcc.com/?q=Dr.+Reddy%27s+Laboratories+Ltd.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Dr.+Reddy%27s+Laboratories+Ltd.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Dr.+Reddy%27s+Laboratories+Ltd.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.drreddys.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.drreddys.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.drreddys.com
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/RDY/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/RDY
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/RDY/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/RDY/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/RDY/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001135951&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/RDY/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/RDY/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/RDY/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/RDY/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=RDY&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=RDY
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/RDY/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=RDY+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=RDY+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=RDY
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=RDY
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=RDY+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/RDY/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=RDY+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/RDY.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=RDY
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/RDY/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/RDY/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/RDY/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/RDY/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/RDY
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/RDY
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/RDY:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=RDY
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=RDY
$RDY DD Notes ~ http://www.ddnotesmaker.com/RDY
Recent RDY News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/20/2024 04:07:22 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/16/2024 12:20:13 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/12/2024 07:05:02 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/10/2024 02:24:51 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/06/2024 10:15:51 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/03/2024 10:06:49 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/30/2024 05:18:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/30/2024 05:11:14 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/29/2024 05:23:11 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/23/2024 04:53:16 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/23/2024 12:19:30 PM
- Dr. Reddy’s Laboratories, Aurigene Pharmaceutical Services, and Kainomyx Announce Potential Partnership for Joint Development of Affordable Anti-Malarial Drug • Business Wire • 08/20/2024 06:42:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/14/2024 03:32:38 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/14/2024 02:05:22 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/13/2024 02:52:15 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/12/2024 10:15:48 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/07/2024 03:31:55 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/06/2024 10:13:14 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/02/2024 10:05:58 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/02/2024 10:05:46 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/01/2024 06:45:38 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/29/2024 06:25:47 PM
- Dr. Reddy’s Receives Positive CHMP Opinion From European Medicines Agency for Its Proposed Rituximab Biosimilar • Business Wire • 07/29/2024 03:55:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/29/2024 03:49:35 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/29/2024 02:55:53 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM